Evidence map›Paper›PMID 33541484›Full record

ReviewEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021

National perinatal survey demonstrates a decreasing seroprevalence of

Eve Robinson, Henriette de Valk, Isabelle Villena, Yann Le Strat, Mathieu Tourdjman

Abstract readReview
In one paragraph

Review in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Systematic review and modelling ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Seroprevalence ofJournal of veterinary science · 2022
    Pooled it
  5. Article
  6. Article
  7. Article
  8. TORCH agents in women of fertile age: towards prevention of congenital infections, Italy, 2019 to 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  9. Estimating the national seroprevalence ofEpidemiology and infection · 2025
    Article
  10. Article
  11. Article
  12. Seroprevalence and associated risk factors ofAfrican health sciences · 2025
    Article
  13. Fatal Toxoplasmosis in Red Kangaroos (Pathogens (Basel, Switzerland) · 2025
    Article
  14. Article
  15. AntenatalAfrican journal of laboratory medicine · 2025
    Article
  16. The European Union One Health 2023 Zoonoses report.EFSA journal. European Food Safety Authority · 2024
    Article
  17. Seroprevalence ofMicroorganisms · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eve RobinsonFrench National Public Health Agency (Santé publique France), Saint-Maurice, France.
Henriette de ValkFrench National Public Health Agency (Santé publique France), Saint-Maurice, France.
Isabelle VillenaNational Reference Centre for Toxoplasmosis, Maison Blanche Hospital, University Reims Champagne-Ardenne, France.
Yann Le StratFrench National Public Health Agency (Santé publique France), Saint-Maurice, France.
Mathieu TourdjmanFrench National Public Health Agency (Santé publique France), Saint-Maurice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundToxoplasmosis during pregnancy can result in congenital anomalies or fetal death. Universal antenatal screening is recommended in France, a strategy in place since the 1970s.AimWe determined the seroprevalence of toxoplasmosis among pregnant women participating in the 2016 national perinatal survey (ENP), compared results with previous ENPs, and investigated factors associated with

Indexed as

ToxoplasmaToxoplasmosisAfrica, NorthernAgedAntibodies, ProtozoanCross-Sectional StudiesFemaleFranceHumansParisPolicyPregnancyPregnant PeopleRisk FactorsSeroepidemiologic StudiesAntibodies, Protozoanpregnant womenprenatal diagnosisseroepidemiologic studiesToxoplasma gondiitoxoplasmosis

Identifiers

PMID33541484
PMCPMC7863230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.